ORBIMED ADVISORS LLC – Edgewise Therapeutics, Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$143.34M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
+23.62%
quarter
Edgewise Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +3.44% | 484.49K shares | 31.24M | $9.84 | 14.56M |
| Q2 2022 | share | Increase | +0.99% | 138K shares | -23.16M | $7.96 | 14.08M |
| Q1 2022 | share | 0.00% | 0 shares | -77.81M | $9.7 | 13.94M | |
| Q4 2021 | share | 0.00% | 0 shares | -18.40M | $14.81 | 13.94M | |
| Q3 2021 | share | 0.00% | 0 shares | -65.95M | $16.6 | 13.94M | |
| Q2 2021 | share | 0.00% | 0 shares | -155.76M | $21.33 | 13.94M | |
| Q1 2021 | share | Increase | 0.00% | 13.94M shares | 453.20M | $32.5 | 13.94M |